期刊文献+

长方案垂体降调节时间对体外受精-胚胎移植结局的影响 被引量:5

Effect of pituitary down-regulation of long protocol controlled ovarian stimulation on the outcomes of in-vitro fertilization and embryo transfer
下载PDF
导出
摘要 目的:探讨长方案垂体降调节时间的长短是否会对体外受精-胚胎移植的结局产生影响。方法:回顾性分析192个应用黄体中期长方案进行控制性超促排卵的IVF—ET周期,根据Gn启动前垂体降调节时间长短分为3组:A组,14~15d(53例);B组,16~18d(98例);C组,〉18d(41例),比较组间的促排卵情况及妊娠结局。结果:3组间注射HcG日子宫内膜厚度,获卵数,受精率,优胚率。移植胚胎数,妊娠率,种植率等均无统计学差异(P〉0.05),Gn总量,Gn用药时间C组高于A,B两组,差异有统计学意义(P〈0.05)。结论:长方案垂体降调节时间长短不影响IVF—ET的妊娠结局,但垂体过度抑制者需增加Gn用量及时间。 Objective To explore the effect of different duration of pituitary down-regulation of long protocol controlled ovarian stimulation on the outcomes of in-vitro fertilization and embryo transfer. Methods A retrospective analysis was conducted on a total of 192 IVF-ET cycles. The cycles were divided into three groups according to the days of successful pituitary down-regulation was confirmed. The three groups were group A ( 14 to 15 days, 53 cycles), group B (16 to 18 days, 98 cycles), and group C (〉18 days, 41 cycles). Results There were no significant differences in endometrial thickness on the day of hCG administration, number of oocytes retrieved, fertilization rate, high-quality embryo rate, number of embryo transfer, pregnancy rate, and implantation rate among the three groups (P 〉 0.05). The tatal dosage of Gn were greater and the time of Gn uses were longer in group C than in groups A and B (P 〈 0.05). Conclusions Different duration of pituitary down-regulation can not affect the outcomes of in-vitro fertilization and embryo transfer. However, dosage and duration of Gn therapy should be increased in the patients with over suppression.
作者 张帆 韦继红
出处 《实用医学杂志》 CAS 北大核心 2013年第22期3683-3685,共3页 The Journal of Practical Medicine
关键词 垂体降调节 长方案 体外受精-胚胎移植 Pituitary down-regulation Long protocol In-vitro fertilization and embryo transfer
  • 相关文献

参考文献10

  • 1胡咏华,徐键,吴丽萍.不同剂量长效抑那通在体外受精-胚胎移植中的治疗效果观察[J].浙江医学,2006,28(11):892-895. 被引量:5
  • 2Porter R N, Smith W, Craft I, et al. Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins. Lancet, 1984,2( 1 ) : 1284-1285.
  • 3Hm'ison R F, Drudy L, Kinsella C B, et al. A randomized pr0speetive study of early follicular or midluteal initiation of long protocol gonadotrophin-releasing hormone in an in vitro fe'tilization program.Fertil Steril, 1996,66(4) :582-586.
  • 4李豫峰,李媛,章汉望,朱桂金,靳镭,岳静,赖巧红,吕艳.适当延后促排卵启动时间有利于IVF-ET结局[J].生殖与避孕,2008,28(8):500-503. 被引量:9
  • 5周红,张波,冯贵雪,方伟芬,刘茵.不同促排卵启动时机对IVF-ET的影响[J].中国计划生育学杂志,2009,17(8):485-487. 被引量:7
  • 6王慧焱,孙海翔,陈华,王玢.长方案垂体降调节对体外受精-胚胎移植结果的影响[J].生殖与避孕,2009,29(2):84-87. 被引量:8
  • 7Ben-Rafael Z, Lipitz S, Bider D, et al. Ovarian hyporesponsiveness in combined gonadotrophin-releasing hcrmone agonist and menotrophin therapy is associated with low serum follicle-stimulating hormone levels [J]. Fertil Steril, 1991,55 (2) :272-275.
  • 8Arnold H M, Henny J M, Alex P E, et al. Early cessation of triptorelin in in vitro fertilization:a double-blind,randomized study [ J ]. Fertil Steril, 2005,83 (4) : 889-896.
  • 9Juan A, Veronica I, Antonio R, et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low-responder IVF patieuts:a prospective, randomized, controlled trial [ J ]. Hum Reprod, 2000, 15(11): 2292-2296.
  • 10Prato L D, Borini A, Trevisi M R, et al. Effect of reduced dGse of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study [J]. Hum Reprod,2001, 16(7) : 1409-1414.

二级参考文献41

  • 1李洁,周灿权,钟依平,欧建平,林雯青,庄广伦.不同小剂量促性腺激素释放激素激动剂在体外受精-胚胎移植中应用的比较[J].中华妇产科杂志,2006,41(4):269-270. 被引量:39
  • 2马黔红,李尚为,黄仲英,韩字研,李培旭,邱东生,韩代文,靳松,李蕾.长效促性腺激素释放激素激动剂用于体外受精-胚胎移植中降调节后延迟卵巢启动时间的探讨[J].实用妇产科杂志,2006,22(10):603-606. 被引量:15
  • 3Barlow DH. GnRH agonists and in vitro fertilization. J Reprod Med, 1998, 43(suppl):245-51.
  • 4Porter RN, Smith W, Craft I, et al. Induction of ovulation for in-vitro fertilization using buserelin and gonadotrophins. Lancet, 1984, 2(1):1 284-5.
  • 5Harrison RF, Drudy L, Kinsella CB, et al. A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotrophin-releasing hormone in an in vitro fertilization program. Fertil Steril, 1996, 66(4):582-6.
  • 6Yaman C, Ebner T, Sommergruber M, et al. Three-dimensional endometrial volume estimation as a predictor of pituitary down-regulation in an IVF-embryo transfer programme. Hum Reprod, 2000, 15(8): 1 698-702.
  • 7Ben-Rafael Z, Lipitz S,Bider D, et al. Ovarian hyporesponsiveness in combined gonadotrophin-releasing hormone agonist and menotrophin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril, 1991, 55(2):272-5.
  • 8Brus L, Lambalk CB, de Koning J, et al. Specific gonadotropin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human preovulatory follicles. Hum Reprod, 1997, 12(4)769-73.
  • 9Arnold HM, Henny JM, Alex PE, et al. Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study. Fertil Steril, 2005, 83(4):889-96.
  • 10Juan A, Veronica I, Antonio R, et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low-responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod, 2000, 15(11):2 292-6.

共引文献23

同被引文献44

  • 1马黔红,李尚为,黄仲英,韩字研,李培旭,邱东生,韩代文,靳松,李蕾.长效促性腺激素释放激素激动剂用于体外受精-胚胎移植中降调节后延迟卵巢启动时间的探讨[J].实用妇产科杂志,2006,22(10):603-606. 被引量:15
  • 2李洁,谭真,任姿,庄广伦.可控制性卵巢刺激治疗中促性腺激素释放激素激动剂降调节与卵巢过度抑制[J].生殖医学杂志,2007,16(5):306-308. 被引量:24
  • 3Komarowska H,Stangierski A,Warmuz-Stangierska I, et al.Differences in the psychological and hormonal presentation oflean and obese patients with polycystic ovary syndrome [J]. NeuroEndocrinol, 2013,34(7) :669-742.
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS ConsensusWorkshdp Group. Revised 2003 consensus on diagnostic criteriaand long-term health risks related to polycystic ovary syndrome[J].Fertil Steril, 2004,81( 1): 19-25.
  • 5Burr Solorzano CM, Belier JP, Abshire MY, et al. Neuroendocrine dysfunction in polycystic ovary syndrome [J ]. Steroids, 2012,77 (4) :332-337.
  • 6Roth' LW, Almshouse AA, Bradshaw, Pieree EL, et al. Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women [J]. Clin Endocrinol, 2014, 81(3) :418-425.
  • 7Stubbs SA, Webber LJ, Stark J, et al. Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries [J]. Clin Endocrinol Metab, 2013 ;98 (8) :3298-3305.
  • 8Kasa-Vubu JZ, Jain V, Welch K. Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females [J]. Fertil Steril, 2010,94( 1 ) : 221-229.
  • 9Comim FV, Hardy K, Franks S. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome [J]. PLoS One, 2013,8(11) : e80416.
  • 10Dean JP, Sprenger CC, Wan J, et al. Response of the insulin- like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation [J]. J Clin Endocrinol Metab, 2013, 98(5) :E820-828.

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部